Clinical Trials Logo
  1. Home
  2. Gastroesophageal Reflux
  3. NCT00681837
  4. Details
NCT00681837 Clinical Trial

Prevalence of Gastroesophageal Reflux During Childhood and Teenage Years in France

Gastroesophageal Reflux Clinical Trial

Official title:
Prevalence of Gastroesophageal Reflux During Childhood and Teenage Years in France

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT00681837
Other study ID # NIS-GFR-DUM-2008/1
Secondary ID
Status Completed
Phase N/A
First received May 19, 2008
Last updated November 17, 2008
Start date May 2008
Est. completion date September 2008

Study information
Verified date November 2008
Source AstraZeneca
Contact n/a
Is FDA regulated No
Health authority France: Haute Autorité de Santé Transparency Commission
Study type Observational

Clinical Trial Summary

The purpose of this study is to assess prevalence of gastrooesophageal reflux during childhood and teenage years in France and to describe patients'symptoms and gastrooesophageal reflux management

Recruitment information / eligibility
Status Completed
Enrollment 2500
Est. completion date September 2008
Est. primary completion date
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group N/A to 17 Years
Eligibility Inclusion Criteria:

- children from 0 to 17years old seen in consultation

Exclusion Criteria:

Study Design

Observational Model: Cohort, Time Perspective: Cross-Sectional

Related Conditions & MeSH terms

Locations
Country Name City State
China Research Site Changsha Hunan
China Research Site Chengdu Sichuan
China Research Site Chongqing Chongqing
China Research Site Fuzhou Fujian
China Research Site Guangzhou Guangdong
China Research Site Hangzhou Zhejiang
China Research Site Hefei Anhui
China Research Site Jinan Shandong
China Research Site Kunming Yunnan
China Research Site Nanchang Jiangxi
China Research Site Nanjing Jiangsu
China Research Site Ningbo Zhejiang
China Research Site Qingdao Shandong
China Research Site Rui'an Zhejiang
China Research Site Shanghai Shanghai
China Research Site Shenzhen Guangdong
China Research Site Suzhou Jiangsu
China Research Site Taiyuan Shanxi
China Research Site Wenzhou Zhejiang
China Research Site Wuhan Hubei
China Research Site Wuxi Jiangsu
China Research Site Xi'an Shanxi
China Research Site Xiamen Guangdong
China Research Site Zhengzhou Henan
China Research Site Zhongshan Guangdong

Sponsors (1)
Lead Sponsor Collaborator
AstraZeneca

Country where clinical trial is conducted

China, 

Outcome
Type Measure Description Time frame Safety issue
Primary assess prevalence of gastrooesophageal reflux during childhood and teenage years in France, particularly 0-1 year-old prevalence and 1-11 year-old prevalence At the end of the study No
Secondary describe patients'symptoms and gastrooesophageal reflux management At the end of the study No
See also
  Status Clinical Trial Phase
Recruiting NCT05561179 - Hyaluronic Acid in Patients With Gastroesophageal Reflux Disease N/A
Withdrawn NCT02213887 - Study of the Effects of Pantoprazole on Levels of Prescribed Psychiatric Medications Phase 4
Completed NCT01946971 - Lansoprazole in Preterm Infants With Gastroesophageal Reflux (GER) Phase 1/Phase 2
Recruiting NCT01825473 - Study of Erythromycin in GER-Associated Apnea of the Newborn N/A
Completed NCT00614536 - Study of Changes in Reflux Symptoms and Reflux Finding Score According to Rabeprazole Treatment Period Phase 4
Completed NCT00373997 - Esophageal and Laryngeal Tissue Changes in Patients Suspected of Having Laryngopharyngeal Reflux Phase 4
Completed NCT00284908 - Dose-Effect of S-Tenatoprazole-Na(STU-Na) 30 mg, 60 mg, 90 mg and 120 mg in Healthy Volunteers Phase 1
Completed NCT00365300 - Study Evaluating the Efficacy and Safety of Pantoprazole in Infants With Symptomatic Gastroesophageal Reflux Disease (GERD) Phase 3
Completed NCT00567021 - German PMS Trial (AWB) to Evaluate Therapy in Reflux Disease and NSAR-Symptoms N/A
Completed NCT00215787 - Investigation of the Association Between Nasal Polyposis and Extraesophageal Reflux Disease N/A
Completed NCT00226044 - Rectal and Oral Omeprazole Treatment of Reflux Disease in Infants. Phase 3
Completed NCT00141960 - Famotidine in Subjects With Non-erosive Gastroesophageal Reflux Disease Phase 2/Phase 3
Completed NCT00291746 - Validation of RDQ Questionnaire Phase 4
Completed NCT01167543 - Relationship and Pathophysiology of Gastroesophageal Reflux and Dental/Periodontal Disease N/A
Completed NCT01048840 - Natural History of Gastroesophageal Reflux (GER) in Children < 12 Years of Age
Completed NCT00181805 - Natural History of Gastroesophageal Reflux (GER) in Children and Adolescents
Terminated NCT01281553 - A Study of Cisapride in Patients With Symptomatic Gastro-Oesophageal Reflux Disease Phase 4
Completed NCT05486169 - Gastroesophageal Reflux Disease After Laparoscopic Sleeve Gastrectomy N/A
Completed NCT04034017 - Gastroesophageal Reflux Disease Among College Students
Terminated NCT03226054 - Determining Risk Factors for Successful PPI Weaning N/A